Data last refreshed: April 20, 2026
Engagement metrics shown below reflect data as of this date. Current LinkedIn stats may differ.
Some great investors preempted the next round at Centivax: the Collison brothers, Structure Fund (Oliver Mulherin & Sam Altman) and Meiji Seika Pharma. "If our data looks good by the end of this y...
Marvell at the Mojo By using a grid of micro-LEDs instead of lasers, Mojo delivers 100x more bandwidth/channel and lower energy/bit. Mojo’s fiber has thousands of physically discrete channels for m...
📲 Last week ZaiNar emerged from stealth. Today they show how powerful a commercial tool their technology is, especially for 5G and carrier customers. The first 5G positioning system to deliver sub-...
ZaiNar emerges today from 9 years of stealth. The company has developed a totally novel technology that tracks the location of anything that emits a radio signal (phones, drones, vehicles, IoT dev...
Generative AI works best when solutions are hard to find, but easy to verify. For AI-driven drug development, the challenge has been our complex systems biology making tox and off-target effects h...
Now and then... The Foresight Institute's Vision Weekend is still going strong — a veritable "brain spa" of futurism. Well, it's back to the Future this December: https://lnkd.in/gT-CGPNc + a ti...
The Stanford interview on AI futures just went live, free here: https://lnkd.in/g-qtBQJx "Steve Jurvetson, An Estonian immigrant’s son reflects on a life shaped by technology: inspired by his fath...
Printing a vast array of externalized human lymph nodes is a great platform for high-throughput experimentation for AI learning loops. Big pharma agrees.
Rank History
Content Categories
Topics & Themes
Top Quartile Benchmarks
Based on top 94 of 376 in Venture Capital